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To the Editor:
We describe a patient with gout who developed serious
multiple system organ failure after the self-administration
of colchicine together with loxoprofen.
A 38-year-old male (height 175 cm, weight 75 kg) with
no pre-existing diseases had been prescribed colchicine
(1 tablet) together with loxoprofen (1 tablet) for gout attack
by his family physician. Following the severest pain attack
at his toe that he had ever experienced, he self-adminis-
tered 30 tablets of colchicine (15 mg) together with ten
loxoprofen tablets (600 mg) within a 6-h period. His pain
subsided 3 h after the last intake of the tablets, but he
presented to our medical center because of gastrointestinal
symptoms including nausea, vomiting, diarrhea, and
hematemesis.
The patient developed acute renal failure on the second
hospital day, and on the third hospital day, he entered a
delirious state, with thrombocytopenia, respiratory failure,
and severe hypotension. Granulocyte colony stimulating
factor (250 lg/day) was administered for his severe pan-
cytopenia on hospital days 4–7. On hospital day 9, his urine
output began to increase, and on hospital day 18, the
patient had been successfully weaned from the mechanical
ventilation. He was discharged from the hospital on hos-
pital day 26. All of the blood and laboratory parameters on
hospital day 25 were within the normal ranges, but alo-
pecia, muscle weakness (MMT 4/5), disappeared ankle
tendon reflex, reduced evoked potentials of peripheral
nerves, including the median, ulnar, and tibial nerves,
remained (Table 1).
The first symptom of this patient was that of gastroin-
testinal tract, followed by the subsequent multiple organ
failure, including the cardiovascular, renal, hepatic, respi-
ratory, myeloproliferative, central and peripheral nervous
systems, which sequentially developed as precisely
described in Stapczynski et al.’s review [1]. The severity of
our patient’s colchicine intoxication correlated well to the
intake doses; i.e., an oral intake of\0.5 mg/kg only exerts
gastrointestinal tract symptoms, that from 0.5 to 0.8 mg/kg
results in multiple organ failure, and an oral intake of
[0.8 mg/kg can be lethal [2]. The total intake of colchicine
in this patient was 15 mg (0.2 mg/kg), and he did not have
any pre-existing diseases. The co-administration of mac-
rolides promotes colchicine’s toxicities [3, 4], but, to our
knowledge, there has been only one report of colchicine
toxicity in association with indomethacin [5]. Colchicine,
anti-inflammatory drugs (NSAIDs), and corticosteroids are
commonly used to treat gout. It would appear that a pos-
sible interaction between colchicine and NSAIDs could
cause a fatal complication.
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Table 1 Blood, serum, and coagulation data during the hospitalization of this patient
Blood, serum, and coagulation data Normal range Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Day 18 Day 25
White blood cells (/ml) 4000–7000 29700 19500 6000 900 400 900 3500 11400 8400
Hemoglobin (g/dl) 14.0–18.0 17.6 16.1 14.4 11.0 9.8 7.9 7.3 8.6 8.7
Hematocrit (%) 40.0–52.0 51.7 47.8 42.5 31.7 27.3 22.6 20.5 24.8 25.7
Platelets (/ml) 15.0–40.0 26.7 11.0 2.7 2.3 1.5 1.3 2.0 10.2 28.1
Prothrombin time (%) 85–120 36 45 76 87 87 93 95 77
Prothrombin time (INR) 2.3 1.89 1.21 1.10 1.10 1.05 1.03 1.20
Activated partial thrombin time (s) 28–40 56.4 70.3 52.0 47.9 38.7 41.7 40.6 37.6
Fibrinogen (mg/dl) 200–400 374 598 799 766 822 692 586 396
Alkaline phosphokinase (U/l) 104–338 2579 2714 1323 565 481 359 327 179 229
Aspartate amino transferase (U/l) 5–40 375 405 344 210 188 177 115 80 29
Alanine amino transferase (U/l) 5–35 52 49 42 44 77 100 79 44 31
Lactate dehydrogenase (U/l) 50–400 12250 13630 10740 4850 2083 1115 835 1290 506
Creatinine phosphokinase (U/l) 20–190 1058 1518 2871 1937 929 283 383 799 36
Blood urea nitrogen (mg/dl) 8–20 42 41 33 28 25 30 32 80 29
Creatinine (mg/dl) 0.6–1.5 4.4 3.8 3.5 2.7 2.8 2.6 2.2 2.8 0.9
C-reactive protein (mg/dl) -0.3 35.51 53.88 54.25 26.85 25.51 19.05 21.05 2.72 0.95
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